Cargando…
Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a common malignancy that has region specific etiologies. Unfortunately, 85% of cases of HCC are diagnosed at an advanced stage. Reliable biomarkers for the early diagnosis of HCC are urgently required to reduced mortality and therapeutic expenditure. We established...
Autores principales: | Gao, Rong, Cheng, Jianhua, Fan, Chunlei, Shi, Xiaofeng, Cao, Yuan, Sun, Bo, Ding, Huiguo, Hu, Chengjin, Dong, Fangting, Yan, Xianzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674760/ https://www.ncbi.nlm.nih.gov/pubmed/26658617 http://dx.doi.org/10.1038/srep18175 |
Ejemplares similares
-
Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis
por: Gong, Zhi-Gang, et al.
Publicado: (2017) -
Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study
por: Chen, Yangqin, et al.
Publicado: (2017) -
Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma
por: Chen, Hongda, et al.
Publicado: (2018) -
Serum Metabolomics Profiling to Identify Biomarkers for Unstable Angina
por: Yao, Wei, et al.
Publicado: (2017) -
Differential metabolic responses in breast cancer cell lines to acidosis and lactic acidosis revealed by stable isotope assisted metabolomics
por: Gao, Jiayue, et al.
Publicado: (2020)